Decisions taken by Neste's Annual General Meeting Neste

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
38
Decisions taken by Neste's Annual General Meeting

Neste Corporation Stock Exchange Release 5 April 2017 at 5 pm. (EET) Decisions taken by Neste's Annual General Meeting Neste Corporation's Annual General Meeting (AGM) was held today at the Helsinki Fair Centre and adopted the company's Financial Statements and Consolidated Financial Statements for 2016 and discharged the Board of Directors and the President & CEO from liability for 2016. Dividend of EUR 1.30 per share The AGM approved the Board of Directors' proposal regarding the distribution of the company's profit for 2016, authorizing payment of a dividend of EUR 1.30 per share. This will be paid to all shareholders included in the register of shareholders maintained by the Euroclear Finland on the record date set for payment of the dividend, which shall be 7 April 2016. Payment will be made on 18 April 2016. Composition of the Board of Directors In accordance with the proposal made by the Shareholders' Nomination Board, the AGM confirmed the membership of the Board of Directors at eight members, and the following were re-elected to serve until the end of the next AGM: Mr. Jorma Eloranta, Ms. Laura Raitio, Mr. Jean-Baptiste Renard, Mr. Willem Schoeber and Mr. Marco Wirén. The following were elected as new members: Ms. Martina Flöel, Ms. Heike van de Kerkhof and Mr. Matti Kähkönen.

Mr. Eloranta was re-elected as Chair and Mr. Matti Kähkönen was elected as new Vice Chair. Board member introductions can be found at company's web site. The AGM decided to keep the remuneration to the Board unchanged as follows:

  • Chair EUR 66,000 a year
  • Vice Chair EUR 49,200 a year
  • members EUR 35,400 a year.

In addition to the annual fee, members of the Board of Directors will receive a meeting fee of EUR 600 for each Board and Committee meeting held in the member's home country and EUR 1,200 for each Board and Committee meeting held in another country, plus compensation for expenses pertaining to the company's travel guidelines. The meeting fee for telephone meetings will be paid according to the fee payable for meetings held in each member's home country. Company Auditor In accordance with a proposal by the Board of Directors, PricewaterhouseCoopers Oy, were appointed as the company's Auditor, with Authorized Public Accountant Mr. Markku Katajisto as the principally responsible auditor for Neste Corporation, until the end of the next AGM. Payment for their services shall be made in accordance with their invoice approved by the Company. Availability of the minutes for review The minutes of the Annual General Meeting shall be available for review in two weeks from the Annual General Meeting at the company's headquarters.

Neste Corporation Kaisa Lipponen Director, Corporate Communications Further information: Matti Hautakangas, General Counsel, tel. +358 (0)50 458 5350

Neste in brief

Neste (NESTE, Nasdaq Helsinki) creates sustainable choices for the needs of transport, businesses and consumers. Our global range of products and services allows customers to lower their carbon footprint by combining high-quality renewable products and oil products to tailor-made service solutions. We are the world's largest producer of renewable diesel refined from waste and residues, and we are also bringing renewable solutions to the aviation and plastics industries. We want to be a reliable partner, whose expertise, R&D and sustainable practices are widely respected. In 2016, Neste's net sales stood at EUR 11.7 billion, and we were on the Global 100 list of the 100 most sustainable companies in the world. Read more: neste.com/en

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Regeneron Faces Legal Heat: Lead Plaintiff Deadline Looms

Updated Category News Views 3

Regeneron’s Tight Spot: Legal Showdown Well, here we go again—Regeneron Pharmaceuticals (NASDAQ:REGN) is under some serious heat. If you're an investor who faced significant losses with this biotech juggernaut, remember that the clock’s ticking down to the wire. By tomorrow, September 14, 2026, you need to decide if you're going to throw your hat in the ring for...

Continue Reading
Surfing Dogs Ride Waves, Support Orphan Pets

Updated Category News Views 3

Waves, Paws, and Passion Who would've thought that dogs catching waves could also catch hearts and wallets? Well, that's exactly what's happening today at Del Mar Dog Beach with the 21st Annual Surf Dog Surf-A-Thon revving up the excitement. It's a sun-soaked day in Rancho Santa Fe, California, right in the thick of things at the longest-running dog surf competition. For...

Continue Reading
GORGIE Unleashes Berry Burst: Target's New Drink Star

Updated Category News Views 5

GORGIE Targets Taste Buds with Berry Burst Ever feel like you're missing out on that energy drink everyone seems to be raving about? Well, GORGIE's out there making some noise again, and this time it's got a new punchy player in the game: Berry Burst. It's not just another drink; it's shaking things up in the energy aisle with its exclusive launch at Target. Modern style...

Continue Reading
PwC US and India Unite for Global Consultancy Powerhouse

Updated Category News Views 6

Rearranging the Consultancy Chessboard Piling onto the game of consultancy realignments, PwC just made a move reminiscent of playing strategy poker. They're tossing together PwC US and PwC India's advisory capabilities for a new joint venture. It’s like pushing two puzzle pieces to make a single colorful picture that stretches from the U.S. all the way to the...

Continue Reading
PANDAG G1 Debuts: Revolutionizing Lawn Care Efficiency

Updated Category News Views 4

The Future of Landscaping Unveiled Get this—PANDAG is set to shake things up at GaLaBau 2026 with their futuristic G1 autonomous mower. This isn't just another piece of lawn equipment; it's practically a tech marvel on wheels, weaving together LiDAR, AI Vision, RTK, and 4G tech to make it the ultimate multitasker for the landscaping industry. We're talking obstacle...

Continue Reading
Ris-Rez May Set New Standard in Relapsed SCLC

Updated Category News Views 6

The Game-Changing Results Innovation in pharmaceuticals sometimes feels like a waiting game, but when a fresh breakthrough like this rolls in, it lights up the whole landscape. Risvutatug rezetecan, or Ris-Rez for short, has shown promising potential in the fight against relapsed small-cell lung cancer (SCLC) that has progressed after platinum-based therapy. Survival...

Continue Reading
Tam-Peli Steps Up in SCLC Battle: Trial Insights

Updated Category News Views 5

Noteworthy Developments in Small-Cell Lung Cancer Treatment Let's dive into a story straight from the world of small-cell lung cancer (SCLC) that doesn't take any prisoners. The antidote making waves is tambotatug pelitecan, or Tam-Peli for short, showcasing its might in the unrelenting fight against relapsed SCLC. The phase III TAISHAN-302 trial puts Tam-Peli...

Continue Reading
UWM Faces Class Action Deadline: Key Insights for Investors

Updated Category News Views 2

The High Stakes Reality for UWM Investors If there's one thing that's certain in this jittery world of investing, it's that losses have a way of waking you up. Right now, anyone tied up with UWM Holdings Corporation (NYSE: UWMC) shares needs to keep their wits about them; we're barreling toward an October 13, 2026 deadline for a class action lawsuit. The clock's ticking...

Continue Reading
Trial Disappointment: No Significant Gains in NSCLC

Updated Category News Views 7

Dissecting the Nuances of the EVOKE-03/KEYNOTE-D46 Trial Every once in a while, we come across a trial that rattles cages in the research community. Today, it's the EVOKE-03/KEYNOTE-D46 trial, a collision of hope and hard-knock reality. This Phase 3 trial, which sought to explore the potential combo of sacituzumab govitecan (SG) and pembrolizumab on metastatic non-small...

Continue Reading
MRI Surveillance Gains Ground in Lung Cancer Care

Updated Category News Views 6

Shifting the Standard: MRI's Rise in SCLC Treatment Here's a twist that baffles the traditionalists—ditch the prophylactic cranial irradiation (PCI) and catch clearer days with MRI surveillance for small-cell lung cancer (SCLC). The latest international phase III MAVERICK trial might just redraw the lines on what's considered standard care in this relentless disease....

Continue Reading

Top 5 Most Recently Viewed Articles

Promising Interim Findings from Medicus Pharma's BCC Study

Updated Category News Views 164

Positive Interim Analysis from Medicus Pharma Ltd Medicus Pharma Ltd. (NASDAQ: MDCX) has recently shared exciting interim results from its SKNJCT-003 Phase 2 clinical study, which focuses on a non-invasive approach to treat basal cell carcinoma (BCC) of the skin. This news marks a significant milestone as the company aims to revolutionize the treatment options available...

Continue Reading
DroneShield's Immediate Response Kit Wins Platinum Award for Innovation

Updated Category News Views 161

DroneShield's Immediate Response Kit Gains Recognition for Innovation DroneShield has recently been awarded the prestigious Platinum Award for Innovation by Military and Aerospace Electronics, showcasing its Immediate Response Kit (IRK) as a cornerstone in drone detection and defeat technology. This award is a testament to the exceptional capabilities of the IRK, which...

Continue Reading
Jefferies Holds ABB Rating; Analysts Assess Mixed Results

Updated Category News Views 65

Jefferies Maintains Hold Rating on ABB Stock Jefferies recently continued its Hold rating for ABB Ltd (NYSE: ABB) and set a price target of CHF50.00, following the company's third-quarter performance report. The report showcased a mixed array of results, with certain metrics outperforming expectations while others showed disappointing trends. During the third quarter, ABB...

Continue Reading
Surgical Clips Market Projected to Reach $1.8 Billion Soon

Updated Category News Views 211

Overview of the Surgical Clips Market Recent analysis of the surgical clips market reveals an impressive valuation of USD 655.9 million in 2023, with projections indicating a potential growth to USD 1.8 billion by 2032. This remarkable increase is attributed to a compound annual growth rate (CAGR) of 11.9% from 2024. Understanding Surgical Clips and Their Importance...

Continue Reading
Public Disclosure of Opening Position by Keywords Studios Plc

Updated Category News Views 74

Public Opening Position Disclosure for Keywords Studios Plc This document provides important information about a public opening position disclosure related to Keywords Studios Plc. It includes details about individuals or entities holding 1% or more of relevant securities. This disclosure is made in accordance with Rule 8.3 of the Takeover Code, which ensures that all...

Continue Reading